Skip to main content
Log in

Sustained Release Theophylline Preparations Practical Recommendations for Prescribing and Therapeutic Drug Monitoring

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Theophylline is an important antiasthmatic medication which has bronchodilator properties. With increased understanding of the relationships of serum theophylline concentration and effect, both adverse and beneficial, oral dosage forms were developed to provide consistent serum theophylline concentrations with the benefit of convenient dosage intervals for long term use.

Since factors such as concurrent disease states, drug interactions and age have a profound effect on theophylline disposition, relatively sophisticated dosage guidelines have evolved. Theophylline is in fact a model drug for the application of pharmacokinetic principles to the individualisation of a treatment regimen.

The purpose of this discussion is to review the relationship of serum theophylline concentration and pharmacodynamic effect and the special properties of oral sustained release theophylline formulations, and to provide a practical approach to prescribing theophylline. Guidelines are provided on the use of serum theophylline concentrations to individualise the theophylline dose, with an analysis of available techniques to monitor theophylline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Antal EJ, Kramer PA, Merick SA, Chapron PJ, Lawson IR. Theophylline pharmacokinetics in advanced age. British Journal of Clinical Pharmacology 12: 637–645, 1981

    Article  PubMed  CAS  Google Scholar 

  • Aranda JV, Sitar DS, Parsons WD, Loughman PM, Neims AH. Pharmacokinetic aspects of theophylline in premature newborns. New England Journal of Medicine 295: 413–416, 1976

    Article  PubMed  CAS  Google Scholar 

  • Bergstrand H. Phosphodiesterase inhibition and theophylline. European Journal of Respiratory Diseases 61 (Suppl. 109): 37–44, 1980

    Google Scholar 

  • Bierman CW, Shapiro GG, Pierson WE, Dorsett CS. Acute and chronic theophylline therapy in exercise-induced bronchospasm. Pediatrics 60: 845–849, 1977

    PubMed  CAS  Google Scholar 

  • Bonham A, Hendeles L, Vaughn L, Weinberger M. The reliability of serum theophylline determinations from clinical laboratories. American Review of Respiratory Disease 122: 829–832, 1980

    PubMed  CAS  Google Scholar 

  • Broussard LA. Theophylline determination by high pressure liquid chromatography. Clinical Chemistry 27: 1931–1932, 1981

    PubMed  CAS  Google Scholar 

  • Conrad KA, Nyman DW. Effects of metoprolol and propranolol on theophylline elimination. Clinical Pharmacology and Therapeutics 28: 463–467, 1980

    Article  PubMed  CAS  Google Scholar 

  • Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma: role of mast cell mediator release. Journal of Allergy and Clinical Immunology 75: 272–278, 1985

    Article  PubMed  CAS  Google Scholar 

  • Dederich RA, Szefler SJ, Green ER. Intrasubject variation in sustained-release theophylline absorption. Journal of Allergy and Clinical Immunology 67: 465–471, 1981

    Article  PubMed  CAS  Google Scholar 

  • Ellis EF. Inhibition of exercise-induced asthma by theophylline. Journal of Allergy and Clinical Immunology 73: 690–692, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ellis EF, Koysooko R, Levy G. Pharmacokinetics in children with asthma. Pediatrics 58: 542–547, 1976

    PubMed  CAS  Google Scholar 

  • Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, et al. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 74: 453–459, 1984

    PubMed  CAS  Google Scholar 

  • Furukawa CT, Shapiro GG, DuHamel T, Weimer L, Pierson WE, et al. Learning and behaviour problems associated with theophylline therapy. Corespondence. Lancet 1: 621, 1984

    Article  PubMed  CAS  Google Scholar 

  • Gardner MJ, Tornatore KM, Jusko WJ, Kanarkowski R. Effects of tobacco smoking and oral contraceptive use on theophylline disposition. British Journal of Clinical Pharmacology 16: 271–280, 1983

    Article  PubMed  CAS  Google Scholar 

  • Goyal RK, Rathan S. Mechanism of lower esophageal sphincter relaxation: action of prostaglandin E1and theophylline. Journal of Clinical Investigation 52: 337–341, 1973

    Article  PubMed  CAS  Google Scholar 

  • Haltom JR, Szefler SJ. Theophylline absorption in young asthmatic children receiving sustained-release formulations. Journal of Pediatrics 107: 805–807, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hauser AR, Lee C, Teague AB. The effect of rifampin on theophylline disposition. Correspondence. Clinical Pharmacology and Therapeutics 33: 254, 1983

    Google Scholar 

  • Hendeles L, Burkey S, Bighley L, Richardson R. Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology 60: 335–338, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hendeles L, Hill MR. Evaluation of an office method for measuring theophylline serum concentrations. Journal of Allergy and Clinical Immunology (in press), 1988

  • Hendeles L, Iafrate RP, Weinberger M. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clinical Pharmacokinetics 9: 95–135, 1984

    Article  PubMed  CAS  Google Scholar 

  • Hendeles L, Massanari M, Weinberger MM. Theophylline. In Evans et al. (Eds) Applied Therapeutics, Spokane, 1986

  • Hendeles L, Weinberger M, Bighley L. Absoute bioavailabilty of oral theophylline. American Journal of Hospital Pharmacy 34: 525–527, 1977

    PubMed  CAS  Google Scholar 

  • Hendeles L, Weinberger M, Bighley L. Disposition of theophylline after a single intravenous infusion of aminophylline. American Review of Respiratory Disease 118: 97–103, 1978

    PubMed  CAS  Google Scholar 

  • Hendeles L, Weinberger M, Milavetz G, Hill M, Vaughn L. Food-induced ‘dose-dumping’ from a once-a-day theophylline product as a cause of theophylline toxicity. Chest 87: 758–765, 1985

    Article  PubMed  CAS  Google Scholar 

  • Herrmann G, Aynesworth MB, Martin J. Successful treatment of persistent dyspnea in ‘status asthmaticus’. Journal of Laboratory Clinical Medicine 23: 135–148, 1937

    Google Scholar 

  • Hill MR, Cribari J, LaBrecque J, Szefler SJ. Twenty-four-hour theophylline concentration profiles during therapy with slow-release theophylline: experience with 122 asthmatic children. Journal of Allergy and Clinical Immunology 79: 20, 1987

    Google Scholar 

  • Hill MR, Szefler SJ. Theophylline update: current controversies. Seminars in Respiratory Medicine 8: 372–380, 1987

    Article  Google Scholar 

  • Jackson RH, McHenry JI, Moreland FB, Raymer WJ, Etter RL. Clinical evaluation of Elixophyllin with correlation of pulmonary function studies and theophylline serum levels in acute and chronic asthmatic patients. Diseases of the Chest 45: 75–85, 1964

    Article  PubMed  CAS  Google Scholar 

  • Jenne JW. Theophylline: a remarkable window to the hepatic microsomal oxidases. Chest 81: 529–530, 1982

    Article  PubMed  CAS  Google Scholar 

  • Jenne JW, Wyze E, Rood FS, MacDonald FM. Pharmacokinetics of theophylline: application to adjustment of the clinical dose of aminophylline. Clinical Pharmacology and Therapeutics 13: 349–360, 1972

    PubMed  CAS  Google Scholar 

  • Jonkman JHG, de Zeeun RA, Schoenmaker R. Interference in the proposed selected method for determination of theophylline by liquid chromatography. Correspondence. Clinical Chemistry 28: 1987, 1982

    PubMed  CAS  Google Scholar 

  • Jonkman JHG, Upton RA. Pharmacokinetic drug interactions with theophylline. Clinical Pharmacokinetics 9: 309–334, 1984

    Article  PubMed  CAS  Google Scholar 

  • Jusko WJ, Poliszczuk A. High pressure liquid Chromatographie and spectrophotometric assays for theophylline in biological fluids. American Journal of Pharmacy 33: 1193–1196, 1976

    CAS  Google Scholar 

  • Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM. Enhanced biotransformation of theophylline in tobacco and marijuana users. Clinical Pharmacology and Therapeutics 24: 405–410, 1978

    PubMed  CAS  Google Scholar 

  • Karim A, Burns T, Wearley L, Streicher J, Palmer M. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle. Clinical Pharmacology and Therapeutics 38: 77–83, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kolbeck RC, Speir WA, Carrier GO, Bransome ED. Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline. Lung 156: 173–183, 1979

    Article  PubMed  CAS  Google Scholar 

  • Koup JR, Brodsky B. Comparison of homogeneous enzyme and high-pressure liquid chromatography for the determination of theophylline concentration in serum. American Review of Respiratory Disease 117: 1135–1138, 1978

    PubMed  CAS  Google Scholar 

  • LaForce CF, Miller MF, Chai H. Effect of erythromycin on theophylline clearance in asthmatic children. Journal of Pediatrics 99: 153–156, 1981

    Article  PubMed  CAS  Google Scholar 

  • Lagas M, Jonkman JH. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet. European Journal of Clinical Pharmacology 24: 761–767, 1983

    Article  PubMed  CAS  Google Scholar 

  • Landay RA, Gonzalez MA, Taylor JC. Effect of phenobarbital on theophylline disposition. Journal of Allergy and Clinical Immunology 62: 27–29, 1978

    Article  PubMed  CAS  Google Scholar 

  • Leo A, Hensch C, Elkins D. Partition coefficients and their uses. Chemists Review (Pakistan) 71: 525–616, 1971

    Article  CAS  Google Scholar 

  • Levy G, Ellis EF, Koysooko R. Indirect plasma theophylline monitoring in asthmatic children by determination of theophylline concentration in saliva. Pediatrics 53: 873–876, 1974

    PubMed  CAS  Google Scholar 

  • Levy G, Koysooko R. Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. Journal of Pediatrics 86: 789–793, 1975

    Article  PubMed  CAS  Google Scholar 

  • Loughnan PM, Sitar DS; Olgilvie RF, Eisen A, Fox Z, et al. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. Journal of Pediatrics 88: 874–879, 1976

    Article  PubMed  CAS  Google Scholar 

  • MacKay AD, Baldwin CJ, Tattersfield AE. Action of intravenously administered aminophylline in normal airways. American Review of Respiratory Disease 27: 609–613, 1983

    Google Scholar 

  • Mangione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ. Pharmacokinetics of theophylline in hepatic disease. Chest 73: 616–622, 1978

    Article  PubMed  CAS  Google Scholar 

  • Marquis JF, Carruthers SG, Spence JD, Brownstone YS, Toogood JH. Phenytoin-theophylline interaction. New England Journal of Medicine 307: 1189–1190, 1982

    Article  PubMed  CAS  Google Scholar 

  • Martin GL, Atkins PC, Dunsky EH, Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. Journal of Allergy and Clinical Immunology 66: 204–212, 1980

    Article  PubMed  CAS  Google Scholar 

  • Maselli R, Casal GL, Ellis EF. Pharmacologic effects of intravenously administered aminophylline in asthmatic children. Journal of Pediatrics 76: 777–782, 1970

    Article  PubMed  CAS  Google Scholar 

  • McWilliams BC, Menendez R, Kelly HW, Howick J. Effects of theophylline on inhaled methacholine and histamine in asthmatic children. American Review of Respiratory Disease 130: 193–197, 1984

    PubMed  CAS  Google Scholar 

  • Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. New England Journal of Medicine 289: 600–603, 1973

    Article  PubMed  CAS  Google Scholar 

  • Muir KT, Jonkman JHG, Tang DS, Kunitani M, Riegelman S. Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high performance liquid chromatography. Journal of Chromatography and Biomedical Applications 221: 85–95, 1980

    Article  CAS  Google Scholar 

  • Nassif EG, Weinberger MM, Shannon D, Guiang SF, Hendeles L, et al. Theophylline disposition in infancy. Journal of Pediatrics 98: 158–161, 1981

    PubMed  CAS  Google Scholar 

  • Nassif EG, Weinberger M, Thompson R, Huntley V. The value of maintenance theophylline in steroid-dependent asthma. New England Journal of Medicine 304: 71–75, 1981

    Article  PubMed  CAS  Google Scholar 

  • Pauwels R, Van Renterghem D, Van Der Straeten M, Johannesson N, Persson CGA. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. Journal of Allergy and Clinical Immunology 76: 583–590, 1985

    Article  PubMed  CAS  Google Scholar 

  • Pedersen S, Møller-Petersen J. Influence of food on absorption rate and bioavailability of a sustained-release theophylline preparation. Allergy 37: 531–534, 1982

    Article  PubMed  CAS  Google Scholar 

  • Pedersen S, Møller-Petersen J. Erratic absorption of a slow-release theophylline sprinkle product. Pediatrics 74: 534–538, 1984

    PubMed  CAS  Google Scholar 

  • Pedersen S, Møller-Petersen J. Influence of food on the absorption of theophylline from a sustained-release formulation (Somophyllin). Clinical Allergy 15: 253–259, 1985

    Article  PubMed  CAS  Google Scholar 

  • Pedersen S, Steffensen G. Absorption characteristics of a once-a-day slow-release theophylline preparation in children with asthma. Journal of Pediatrics 110: 953–959, 1987

    Article  PubMed  CAS  Google Scholar 

  • Persson CGA, Erjfat I, Karlsson J-A. Adenosine antagonism: a less desirable characteristic of xanthine drugs? Acta Pharmacologica et Toxicologica (Copenhagen) 49: 317–320, 1981

    Article  CAS  Google Scholar 

  • Petty TL, Cherniack RM, Fisher JH, King TE, Schwarz MI. Seminars in respiratory medicine, Vol. 8, No., Thieme Medical Publishers Inc., New York, 1987

    Google Scholar 

  • Pollack GM, Baswell B, Szefler SJ, Shen DD. Comparison of inter-and intra-subject variation in oral absorption of theophylline from sustained-release products. International Journal of Pharmaceutics 21: 3–16, 1984

    Article  CAS  Google Scholar 

  • Pollock J, Kiechel F, Cooper D, Weinberger M. Relationship of serum theophylline concentration to inhibition of exercise-induced bron-chospasm and comparison with cromolyn. Pediatrics 60: 840–844, 1977

    PubMed  CAS  Google Scholar 

  • Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN. Inhibition of theophylline clearance by cimetidine but not ranitidine. Archives of Internal Medicine 144: 484–486, 1984

    Article  PubMed  CAS  Google Scholar 

  • Powell JR, Vozeh S, Hopewell P. Theophylline disposition in acutely ill hospitalized patients: the effect of smoking, heart failure, severe airway obstruction and pneumonia. American Review of Respiratory Disease 118: 229–238, 1978

    PubMed  CAS  Google Scholar 

  • Prince RA, Wing DS, Weinberger MM, Hendeles LS, Riegelman S. Effect of erythromycin on theophylline kinetics. Journal of Allergy and Clinical Immunology 68: 427–432, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rachelefsky GS, Wo J, Adelson J, Mickey MR, Spector SL, et al. Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics 78: 1133–1138, 1986

    PubMed  CAS  Google Scholar 

  • Reitberg DP, Bernhard H, Schentag JJ. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Annals of Internal Medicine 95: 582–585, 1981

    PubMed  CAS  Google Scholar 

  • Richer C, Mathieu M, Bah H. Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin. Clinical Pharmacology and Therapeutics 31: 579–586, 1982

    Article  PubMed  CAS  Google Scholar 

  • Rogers R, Wiener MB, Hill M, Szefler SJ. Theophylline absorption from two sustained-release products: implications for therapeutic drug monitoring. American Review of Respiratory Disease, 136: 1168–1173, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rogers RJ, Kalisker A, Wiener MB, Szefler SJ. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children. Journal of Pediatrics 106: 496–501, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rosen JP, Danish M, Ragni M, Saccar CL, Yafife SJ, et al. Theophylline pharmacokinetics in the young infant. Pediatrics 64: 248–251, 1979

    PubMed  CAS  Google Scholar 

  • Rosenberry KR, Defusco CJ, Mansmann HC, McGeady SJ. Reduced theophylline half-life by carbamazepine therapy. Journal of Pediatrics 102: 472–474, 1983

    Article  PubMed  CAS  Google Scholar 

  • Scott PH, Tabachnik E, MacLeod S, Correia J, Newth C, et al. Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. Journal of Pediatrics 99: 476–479, 1981

    Article  PubMed  CAS  Google Scholar 

  • Shack JA, Waxier SH. An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues. Journal of Pharmacology and Experimental Therapeutics 97: 283–291, 1949

    Google Scholar 

  • Shaw LM, Fields L, Mayock R. Factors influencing theophylline serum protein binding. Clinical Pharmacology and Therapeutics 32: 490–496, 1982

    Article  PubMed  CAS  Google Scholar 

  • Sips AP, Edelbrock PM, Kulstad S, deWolff FA, Dijkman JH. Food does not affect bioavailability of theophylline from Theolin Retard. European Journal of Clinical Pharmacology 26: 405–407, 1984

    Article  PubMed  CAS  Google Scholar 

  • Sorkin EM, Darvey DL. Review of cimetidine drug interactions. Drug Intelligence and Clinical Pharmacy 17: 110–120, 1983

    PubMed  CAS  Google Scholar 

  • Springer C, Goldenberg B, Ben-Dov I, Godfrey S. Clinical, physiologic and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. Journal of Allergy and Clinical Immunology 76: 64–69, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tang-Liu DDS, Williams RL, Riegelman S. Non-linear theophylline elimination. Clinical Pharmacology and Therapeutics 31: 358–359, 1981

    Google Scholar 

  • Thompson RD, Nagasawa HT, Jenne JW. Determination of theophylline and its metabolites in human urine and serum by high pressure liquid chromatography. Journal of Laboratory and Clinical Medicine 84: 584–593, 1974

    PubMed  CAS  Google Scholar 

  • Upton RA, Sansom L, Guentert TW, Powell JR, Thiercelin J-F, et al. Evaluation of absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. Journal of Pharmacokinetics and Biopharmaceutics 8: 229–242, 1980

    Article  PubMed  CAS  Google Scholar 

  • Vaughn LM, Weinberger MM, Milavetz G, Tillson S, Ellis E, et al. Multicentre evaluation of disposable visual measuring device to assay theophylline from capillary blood sample. Lancet 1: 184–186, 1986

    Article  Google Scholar 

  • Wald JA, Friedman BF, Farr RS. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma. Journal of Allergy and Clinical Immunology 78: 36–43, 1986

    Article  PubMed  CAS  Google Scholar 

  • Weddle OH, Mason WD. Rapid determination of theophylline in human plasma by high pressure liquid chromatography. Journal of Pharmaceutical Sciences 65: 865–868, 1976

    Article  PubMed  CAS  Google Scholar 

  • Weinberger M, Hudgel D, Spector S, Chidsey C. Inhibition of theophylline clearance by tholeandomycin. Journal of Allergy and Clinical Immunology 59: 228–231, 1977

    Article  PubMed  CAS  Google Scholar 

  • Weinberger M, Lindgren S, Bender B, Lerner JA, Szefler S. Effects of theophylline on learning behavior: reason for concern or concern without reason? Journal of Pediatrics 111: 471–474, 1987

    Article  PubMed  CAS  Google Scholar 

  • Weinberger MM, Ginchansky E. Dose-dependent kinetics of theophylline disposition in asthmatic children. Journal of Pediatrics 91: 820–824, 1977

    Article  PubMed  CAS  Google Scholar 

  • Yurchak AM, Jusko WJ. Theophylline secretion into breast milk. Pediatrics 57: 518–520, 1976

    PubMed  CAS  Google Scholar 

  • Zell M, Curtis RA, Troyer WG, Fischer JH. Volume of distribution of theophylline in acute exacerbations of reversible airway disease. Chest 87: 212–216, 1985

    Article  PubMed  CAS  Google Scholar 

  • Zwillich CW, Sutton FD Neff TA, Cohn WM, Matthay RA, et al. Theophylline-induced seizures in adults. Annals of Internal Medicine 82: 784–787, 1975

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glynn-Barnhart, A., Hill, M. & Szefler, S.J. Sustained Release Theophylline Preparations Practical Recommendations for Prescribing and Therapeutic Drug Monitoring. Drugs 35, 711–726 (1988). https://doi.org/10.2165/00003495-198835060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835060-00006

Keywords

Navigation